Pre-Test for Respiratory Syncytial Virus Infection in Infants and Young Children monograph
Page One
1.
What percentage of children have become seropositive for RSV by 2 years of age? (Choose one answer.)
A. 10%
B. 25%
C. 50%
D. 75%
E. Almost 100%
2.
Onset of RSV activity usually occurs the earliest in which region of the United States? (Choose one answer.)
A. Midwest
B. Northeast
C. Midwest and northeast
D. South
E. West
3.
Which is NOT a common acute complication among children hospitalized with RSV infection? (Choose one answer.)
A. Apnea
B. Dehydration
C. Hypoxia
D. Otitis media
E. Secondary bacterial infection
4.
Recurrent wheezing occurs in approximately what percentage of children, for up to 11 years of age, who have had RSV LRTI? (Choose one answer.)
A. 10%
B. 25%
C. 50%
D. 75%
E. Almost 100%
5.
Which of the following therapies is most likely to be of benefit in an infant admitted to the hospital because of worsening respiratory distress due to confirmed RSV infection? (Choose one answer.)
A. Broad-spectrum antibiotics
B. Bronchodilators
C. Intravenous corticosteroids
D. Nebulized ribavirin
E. Supportive care
6.
Which of the following is true about the use of β2-agonists in infants <1 year of age with first-time wheezing due to RSV infection? (Choose one answer.)
A. β2-agonists decrease hospitalization rates in these infants
B. β2-agonists decrease mortality rates in these infants
C. β2-agonists increase oxygen saturation in these infants
D. β2-agonists should be tried in most of these infants
E. β2-agonists are not recommended for routine use in these infants
7.
Which of the following approaches is recommended by the AAP for preventing serious RSV infection in high-risk infants and young children? (Choose one answer.)
A. Antibiotic therapy
B. Antiviral therapy
C. Intravenous polyclonal RSV immunoglobulin
D. Palivizumab
E. RSV vaccine
8.
According to the AAP guidelines, monthly injections of palivizumab during RSV season are recommended for children <24 months of age with which underlying condition? (Choose one answer.)
A. Asthma
B. BPD
C. Cystic fibrosis
D. Failure to thrive
E. Low birth weight
9.
According to the AAP guidelines, premature infants born between 32 and 35 weeks of gestational age should: (Choose one answer.)
A. Always receive palivizumab
B. Only receive palivizumab if they are of low birth weight
C. Only receive palivizumab if they are <6 months of age at the start of RSV season
D. Only receive palivizumab if they are <6 months of age at the start of RSV season and have at least 2 risk factors
E. Never receive palivizumab
10.
If an infant currently receiving prophylactic treatment with palivizumab experiences a breakthrough RSV infection, which is the best course of action? (Choose one answer.)
A. Continue palivizumab and add supportive care
B. Discontinue palivizumab and add supportive care
C. Discontinue palivizumab and add a bronchodilator
D. Discontinue palivizumab and add an intravenous corticosteroid
E. Discontinue palivizumab and add nebulized ribavirin
Survey Software
powered by SurveyGizmo
